Evidence map›Paper›PMID 36769017›Full record

ArticleInternational journal of molecular sciences2023

Enhanced Antibacterial Activity of Substituted Derivatives of NCR169C Peptide.

Dian H O Howan, Sándor Jenei, János Szolomajer, Gabriella Endre, Éva Kondorosi, Gábor K Tóth

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dian H O HowanDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, H-6720 Szeged, Hungary.
Sándor JeneiBiological Research Centre, Institute of Plant Biology, H-6726 Szeged, Hungary.
János SzolomajerDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, H-6720 Szeged, Hungary.
Gabriella EndreBiological Research Centre, Institute of Plant Biology, H-6726 Szeged, Hungary.ORCID 0000-0001-9493-7395
Éva KondorosiBiological Research Centre, Institute of Plant Biology, H-6726 Szeged, Hungary.
Gábor K TóthDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, H-6720 Szeged, Hungary.

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Balzan research grant Balzan research grantHungarian National Office for Research, Development and Innovation (NKFIH) GINOP 2.3.2-15-2016-00014Hungarian National Office for Research, Development and Innovation (NKFIH) GINOP 2.3.2-15-2016-00015Ministry of Human Capacities TKP2021-EGA-32NIGMS NIH HHS R01 GM129325NKFIH Frontline Research KKP129924
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsTryptophanBacteriaMicrobial Sensitivity TestsPeptidesStaphylococcus aureusAnti-Bacterial AgentsPeptidesTryptophanantimicrobial peptidesantimicrobial resistanceMedicago truncatulamodified trytophansnodule-specific cysteine-rich

Identifiers

PMID36769017
PMCPMC9917201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.